In Pharmaceutical Industries OOS investigation and root cause identification is very important topic. If you are not able to identify the exact root cause, then your effort should be looked in your investigation.
Here I am sharing case study to understand it in a better way-
Description of Event:
OOS result observed in dissolution test.
One unit result is 800% and other 5-units are well with in limit (about 98%) -Limit is NLT 75%(Q).
Preliminary investigation:
It is aberrant result (Not a true representative result), but no any obvious cause is identified.
Re-measurement:
Hypothesis testing is performed to rule out instrument error, vial filling error, dilution error.
But no any error is identified and all above possibilities are ruled out.
Now what is the next step. . .We know that this is a aberrant result, but we could not able to proove that.
We can not perform the Re-analysis by saying that this is a erratic result. Our effort to identify the root cause should be looked in our investigation.
Good investigator approach:
The next step of good investigator which he can take to make this investigation more adequate.
Step-1
Run the subject vial sample and one reference vial sample on PDA detector and check the peak purity and spectrum.
Step-2
If peak purity of subject vial is failed and reference vial peak purity is passed. Then there is a chance of sample contamination with foreign materials, which give response at same retention time.
Step-3
Now our next step to identify that from where this contamination come to the sample. There is a possibility that bowl was not properly cleaned and previous sample trace remains in the dissolution bowl.
To rule out this possibility we have to perform some experiments like previous product (about 20ppm solution) injection should be injected in same chromatographic system and if peak observed at same RT then this investigation looks better. But if no peak observed then we have to inject few more product solution based on possibility and evaluation of our investigation.
Step-4
If no root cause is identified in step-3, then in step-4 we have to forward this investigation to manufacturing to rule out any product contamination (inject previous product on same chromatographic conditions) in manufacturing.
By all these efforts, if we will do the Re-analysis and release the batch. It will give confidence to auditor that there is no any issue with the product quality.
Here I am sharing case study to understand it in a better way-
Description of Event:
OOS result observed in dissolution test.
One unit result is 800% and other 5-units are well with in limit (about 98%) -Limit is NLT 75%(Q).
Preliminary investigation:
It is aberrant result (Not a true representative result), but no any obvious cause is identified.
Re-measurement:
Hypothesis testing is performed to rule out instrument error, vial filling error, dilution error.
But no any error is identified and all above possibilities are ruled out.
Now what is the next step. . .We know that this is a aberrant result, but we could not able to proove that.
We can not perform the Re-analysis by saying that this is a erratic result. Our effort to identify the root cause should be looked in our investigation.
Good investigator approach:
The next step of good investigator which he can take to make this investigation more adequate.
Step-1
Run the subject vial sample and one reference vial sample on PDA detector and check the peak purity and spectrum.
Step-2
If peak purity of subject vial is failed and reference vial peak purity is passed. Then there is a chance of sample contamination with foreign materials, which give response at same retention time.
Step-3
Now our next step to identify that from where this contamination come to the sample. There is a possibility that bowl was not properly cleaned and previous sample trace remains in the dissolution bowl.
To rule out this possibility we have to perform some experiments like previous product (about 20ppm solution) injection should be injected in same chromatographic system and if peak observed at same RT then this investigation looks better. But if no peak observed then we have to inject few more product solution based on possibility and evaluation of our investigation.
Step-4
If no root cause is identified in step-3, then in step-4 we have to forward this investigation to manufacturing to rule out any product contamination (inject previous product on same chromatographic conditions) in manufacturing.
By all these efforts, if we will do the Re-analysis and release the batch. It will give confidence to auditor that there is no any issue with the product quality.